Global Ophthalmic Viscoelastic Devices Market to Reach $3.35 Billion by 2029, Growing at 5% CAGR

What market dynamics are playing a key role in accelerating the growth of the ophthalmic viscoelastic devices market?
The ophthalmic viscoelastic devices market is predicted to grow as the frequency of cataracts and glaucoma increases. Cataracts involve cloudiness and decreased vision in the eyes, while glaucoma pertains to a set of eye diseases that harm the optic nerve, typically due to elevated pressure within the eye. If not addressed, it can lead to loss of vision and even blindness. Ophthalmic viscoelastic devices (OVDs), which are essentially gel-like substances, are utilized during eye operations, including those for cataracts and specific glaucoma procedures. For example, the BrightFocus Foundation, a US-based nonprofit organization, reported in October 2022 that there were 80 million global glaucoma victims. This number is expected to increase to nearly 111 million by 2040. Thus, the rising prevalence of cataracts and glaucoma is fueling the expansion of the ophthalmic viscoelastic devices market.

Get Your Ophthalmic Viscoelastic Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/ophthalmic-viscoelastic-devices-global-market-report

How will the growth rate of the ophthalmic viscoelastic devices market shape industry trends by 2034?
The market size for ophthalmic viscoelastic devices has been displaying steady growth in the past few years. It is anticipated to expand from $2.65 billion in 2024 to $2.75 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.4%. This growth during the historic period has been fueled by a rise in cataract surgeries, progress in ophthalmic surgical methods, demographic influences of an aging population, a higher prevalence of eye diseases, and improved patient education and accessibility to eye healthcare services.

The market for ophthalmic viscoelastic devices is predicted to experience substantial growth in the upcoming years, escalating to "$3.35 billion in 2029 with a compound annual growth rate (CAGR) of 5.1%. The upward trend in the projected time is due to advancements in device technology, increased use in eye surgery, surging demand for top-tier intraocular lenses, worldwide initiatives for eye health and visual care, market expansion into developing economies, collaborations, and educational programs in the field of ophthalmology. Notable movements in the forecast period consist of personalized ophthalmic solutions, regulatory adherence and quality guarantee, collaborations and alliances, consumer inclination towards high-end products, and ongoing investigation and innovation.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10665&type=smp

What trends are poised to drive the future success of the ophthalmic viscoelastic devices market?
The developing trend in the ophthalmic viscoelastic devices market is centered around product innovations. In order to remain competitive, firms are integrating new advancements in their business models. For example, in April 2023, the American eye health company Bausch + Lomb Corporation unveiled the StableVisc cohesive ophthalmic viscosurgical device (OVD) and the TotalVisc Viscoelastic System. The purpose of StableVisc, a cohesive OVD, is to preserve room in the eye's anterior chamber, thereby facilitating the removal and replacement of the congenital foggy lens. In addition, the TotalVisc Viscoelastic System, which incorporates both StableVisc and ClearVisc (a dispersing OVD), safeguards ocular tissue throughout the surgical process. These items comprise sodium hyaluronate and sorbitol, unique compounds that have exhibited superior free radical sweeping capabilities when contrasted with other OVDs in lab studies. The TotalVisc OVD provides combined mechanical and chemical defences.

Which primary segments of the ophthalmic viscoelastic devices market are driving growth and industry transformations?
The ophthalmic viscoelastic devices market covered in this report is segmented -

1) By Product Type: Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic
2) By Application: Cataract Surgery, Glaucoma Surgery, Corneal Transplant, Vitreoretinal Surgery
3) By End User: Hospital, Ophthalmology Clinics, Other End-Users

Subsegments:
1) By Cohesive Ophthalmic Viscoelastic: Sodium Hyaluronate, Hyaluronic Acid, Other Cohesive Types
2) By Dispersive Ophthalmic Viscoelastic: Sodium Chondroitin Sulfate, Dispersive Hydrogel, Other Dispersive Types

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10665

Which geographical regions are pioneering growth in the ophthalmic viscoelastic devices market?
North America was the largest region in the ophthalmic viscoelastic devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global ophthalmic viscoelastic devices market report during the forecast period. The regions covered in the ophthalmic viscoelastic devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the ophthalmic viscoelastic devices market landscape?
Major companies operating in the ophthalmic viscoelastic devices market include Altacor Ltd., Bausch Health Companies Inc., Bohus Biotech Ab, Carl Zeiss Meditec Ag, Cima Technology Inc., Eyekon Medical Inc., Haohai Biological Technology Co. Ltd., Johnson & Johnson Pvt. Ltd., Novartis International AG, Rumex International Corporation, Rayner Intraocular Lenses Limited, Aurolab, Ophtechnics Unlimited, Truviz Ophthalmic, Beye LLC, Alcon Inc., Beaver Visitec Limited, Neu Micromed International Pvt. Ltd., Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., OcuCo Ltd., Precision Lens Co. Ltd., Croma Pharma GmbH, Medicontur Medical Engineering Ltd., Rhein Medical Inc., MicroSurgical Technology, FCI Ophthalmics Inc., Hanita Lenses Ltd., HOYA Medical Singapore Pte. Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10665&type=smp

What Is Covered In The Ophthalmic Viscoelastic Devices Global Market Report?

• Market Size Forecast: Examine the ophthalmic viscoelastic devices market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the ophthalmic viscoelastic devices market for a structured understanding.
• Key Players Overview: Analyze major players in the ophthalmic viscoelastic devices market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the ophthalmic viscoelastic devices market.
• Segment Contributions: Evaluate how different segments drive overall growth in the ophthalmic viscoelastic devices market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the ophthalmic viscoelastic devices market.
• Industry Challenges: Identify potential risks and obstacles affecting the ophthalmic viscoelastic devices market.
• Competitive Landscape: Review strategic developments in the ophthalmic viscoelastic devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.